Search
PD-1 Blocker Safe in Childhood Cancers. But Does It Work?
- OPACC
- Mar 19, 2020
- 1 min read
PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were limited to those with lymphoma, a phase I/II study found.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...